Q3

• Interim Report Third Quarter 2025, July 1 – September 30 Novakand Pharma AB (publ.), org.no. 556806-8851

  21 November 2025

• Interim Report Third Quarter 2024, July 1 – September 30 Kancera AB (publ.), org.no. 556806-8851

  15 November 2024

• Interim Report Third Quarter July 1 – September 30, 2023 Kancera AB (publ.), org.no. 556806-8851

  17 November 2023

• Interim report third quarter, January 1 – September 30, 2022, Kancera ab (publ.), org.nr. 556806-8851

  27 October 2022

• Interim report for third quarter 2021,1 January – 30 September 2021 Kancera AB (publ.), org.nr. 556806-8851

  19 November 2021

• Interim report for the third quarter 2020, January 1st – September 30th, 2020

  20 November 2020

• Interim report for the third quarter 2019, 1 January – 30 September 2019

  26 November 2019

• INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 30th September 2018

  23 November 2018

• INTERIM REPORT FOR KANCERA  AB (publ) 1st January – 30th September 2017

  17 November 2017

• Interim Report for Kancera AB (publ) Q3 2016, January 1 – September 30, 2016

  18 November 2016